Breaking News

GenScript Biotech Opens Biologics R&D and Production Center

Meets all U.S., EU and Chinese GMP requirements

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GenScript Biotech Corp., a biologics contract development and manufacturing organization (CDMOs) in China, said its biologics research and development (R&D) and production center was formally put into operation on July 11, 2019. This represents another milestone for the firm following the groundbreaking ceremony of its commercial manufacturing center in Zhenjiang, Jiangsu province.   Construction of the Nanjing-based, 9,300-square-meter biologics R&D and production center was completed i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters